EcoDrugPlus

60s Acidic Ribosomal Protein P1-Like

Ensembl ID : ENSSTUG00000047603
Gene Symbol: LOC115174066
3 Cross references
374 Possible Orthologues:

60s Ribosomal Protein L10

Ensembl ID : ENSSTUG00000013034
Gene Symbol: LOC115168747
3 Cross references
403 Possible Orthologues:

60s Ribosomal Protein L10a

Ensembl ID : ENSSTUG00000045725
Gene Symbol: LOC115208153
3 Cross references
316 Possible Orthologues:

60s Ribosomal Protein L10a-Like

Ensembl ID : ENSSTUG00000033645
Gene Symbol: LOC115150277
3 Cross references
316 Possible Orthologues:

60s Ribosomal Protein L11

Ensembl ID : ENSSTUG00000033117
Gene Symbol: LOC115175962
3 Cross references
282 Possible Orthologues:

60s Ribosomal Protein L11

Ensembl ID : ENSSTUG00000045518
Gene Symbol: LOC115173455
3 Cross references
282 Possible Orthologues:

60s Ribosomal Protein L13

Ensembl ID : ENSSTUG00000038563
Gene Symbol: LOC115203070
3 Cross references
269 Possible Orthologues:

60s Ribosomal Protein L13-Like

Ensembl ID : ENSSTUG00000049934
Gene Symbol: LOC115167272
3 Cross references
269 Possible Orthologues:

60s Ribosomal Protein L13a

Ensembl ID : ENSSTUG00000015660
Gene Symbol: LOC115172869
3 Cross references
363 Possible Orthologues:

60s Ribosomal Protein L13a-Like

Ensembl ID : ENSSTUG00000021253
Gene Symbol: LOC115162571
3 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L14-Like

Ensembl ID : ENSSTUG00000044741
Gene Symbol: LOC115175330
3 Cross references
303 Possible Orthologues:

60s Ribosomal Protein L14-Like

Ensembl ID : ENSSTUG00000020024
Gene Symbol: LOC115173835
3 Cross references
303 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).